For instance, under glucose-limited conditions, it was observed that acute myeloid leukemia (AML) cells 35, pancreatic cancer cells 36, and lung cancer cells 34 augment fructose metabolism through enhanced expression and activity of the fructose transporter GLUT5, supporting malignant proliferation. This evidence concerns the gene SLC2A5 and lung cancer.